CurrentRheuma
Get Weekly

Topic · page 5 of 40

Rheumatoid arthritis

Early and established rheumatoid arthritis in adults: diagnosis and prediction (clinically suspect arthralgia, people at risk), treat-to-target, conventional, biologic and targeted synthetic drugs, tapering and withdrawal, glucocorticoids, extra-articular disease and rheumatoid arthritis–associated interstitial lung disease

Briefs 161–200 of 1,564 placed here, newest publication first

Briefs in Rheumatoid arthritis

Newest publication first

  1. RMD Open

    Sustaining remission in rheumatoid arthritis: the role of clinical deep remission and its implications for drug tapering

    Cohort study

  2. Arthritis Res Ther

    Ultrasound evaluation of muscle quality in rheumatoid arthritis: a reliability study of the Spanish Ultrasound Muscle Assessment in Rheumatoid Arthritis (SpUMAR) score

    Research article

  3. Arthritis Care Res (Hoboken)

    A Rheumatoid Arthritis Training Program for Primary Care Providers on the Navajo Nation

    Research article

  4. Rheumatology (Oxford)

    Estrogen replacement therapy and physical function in rheumatoid arthritis

    Cohort study

  5. Ann Rheum Dis

    Response of ultrasound-assessed synovitis to baricitinib, in monotherapy and combined with methotrexate, compared with etanercept in rheumatoid arthritis: a randomised, international, multicentre trial

    Randomized controlled trial

  6. Lancet Rheumatol

    Effectiveness and persistence of biological and targeted synthetic treatment in patients with rheumatoid arthritis and chronic kidney disease: a multicentre, prospective cohort study

    Cohort study

  7. Arthritis Rheumatol

    Association of Epigenetic Trajectory With Development of Clinical Rheumatoid Arthritis in Individuals With Anti–Citrullinated Protein Antibody Positivity: Targeting Immune Responses for Prevention of Rheumatoid Arthritis ( TIP ‐ RA )

    Cohort study

  8. Arthritis Res Ther

    Characteristics and safety outcomes of rheumatoid arthritis patients treated with AMGEVITA® in the United Kingdom using data from a national register

    Cohort study

  9. Arthritis Rheumatol

    auto scoRA : Deep Learning to Automate Sharp/van der Heijde Scoring of Radiographic Damage in Rheumatoid Arthritis

    Diagnostic or prognostic study

  10. Semin Arthritis Rheum

    Superior drug retention of selective JAK1 inhibitors compared to pan-JAK inhibitors in rheumatoid arthritis: A meta-analysis of real-world evidence

    Meta-analysis

  11. Arthritis Res Ther

    Immunoglobulin G and plasma glycome in early rheumatoid arthritis differ from matched controls and link less fat-free mass to an accelerated aging phenotype: an exploratory study

    Cohort study

  12. Arthritis Rheumatol

    Coverage Generosity of Novel Antirheumatic Drugs in Medicare Advantage and Stand‐Alone Part D Plans

    Cross-sectional study

  13. Rheumatology (Oxford)

    Identification and functional characterization of urinary protein biomarkers for RA

    Mechanistic study

  14. Arthritis Rheumatol

    Integrative Multiomics Approaches Identify Biomarkers Associated With Progression From Arthralgia to Rheumatoid Arthritis

    Cohort study

  15. Semin Arthritis Rheum

    Validity and utility of a single-item patient-reported measure of treatment-related bother in rheumatoid arthritis: A cross-sectional OMERACT study

    Cross-sectional study

  16. Scand J Rheumatol

    Clinical and radiological distinctiveness of anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis-associated interstitial lung disease: a retrospective cohort study

    Cohort study

  17. Arthritis Rheumatol

    Autoantibodies to Joint‐Related Peptides Are Associated With Onset of Rheumatoid Arthritis in Presymptomatic Seronegative Individuals

    Diagnostic or prognostic study

  18. Arthritis Rheumatol

    Baseline Interleukin‐10 Levels as a Predictive Biomarker for Achieving Clinical Response With Abatacept in Patients Who Were Disease‐Modifying Antirheumatic Drug Naive and Anti–Citrullinated Protein Antibody Positive With Early Rheumatoid Arthritis

    Secondary analysis

  19. Ann Rheum Dis

    Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2025 update of the EULAR recommendations for the management of rheumatoid arthritis

    Research article

  20. Arthritis Rheumatol

    Association of Clonal Hematopoiesis With Incident, Late‐Onset, Seropositive Rheumatoid Arthritis

    Cohort study

  21. Lancet Rheumatol

    Associated lifestyle factors and comorbidities of difficult-to-treat rheumatoid arthritis: a systematic review and meta-analysis

    Meta-analysis

  22. Ann Rheum Dis

    Upadacitinib vs adalimumab in patients with rheumatoid arthritis and a prior inadequate response or intolerance to a tumour necrosis factor inhibitor: 12-week results from the randomised, double-blind, SELECT-SWITCH study

    Randomized controlled trial

  23. J Rheumatol

    Prevalence of Comorbidities and Poor Prognostic Factors Among Patients With Rheumatoid Arthritis in Bangladesh

    Cross-sectional study

  24. Clin Exp Rheumatol

    Serum glutathione peroxidase 1 levels associate with cardiometabolic comorbidity in rheumatoid arthritis

    Cross-sectional study

  25. Arthritis Rheumatol

    Inferring Rheumatoid Arthritis Disease Activity Status From the Electronic Health Records Across Health Systems

    Diagnostic or prognostic study

  26. Arthritis Rheumatol

    PEPITEM Regulates the Synovial Microenvironment During Immune‐Mediated Inflammatory Arthritis to Limit Disease

    Mechanistic study

  27. Rheumatology (Oxford)

    A clinical-radiomics integrated nomogram for predicting 5-year survival in RA-associated interstitial lung disease

    Diagnostic or prognostic study

  28. Ann Rheum Dis

    RA and PsA synovial tissue single-cell analysis demonstrates differential fibroblast populations with distinct phenotypes and functional capacities

    Mechanistic study

  29. Ann Rheum Dis

    Differentiation of physiological from pathological bone erosions in rheumatoid arthritis: an 8-year HR-pQCT study of the second metacarpal head

    Case-control study

  30. RMD Open

    Immunoprecipitation-mass spectrometry reveals known and novel (NatC, BCS1L ) antinuclear antibodies in rheumatoid arthritis

    Mechanistic study

  31. RMD Open

    Birth length and perinatal exposures and rheumatoid arthritis risk in the E3N cohort

    Cohort study

  32. RMD Open

    Persistent arthritis develops in joints previously affected by palindromic flares: a longitudinal study investigating the transition from palindromic rheumatism to rheumatoid arthritis

    Cohort study

  33. Ann Rheum Dis

    Safety of synthetic and biological DMARDs: a systematic literature review informing the 2025 update of the EULAR recommendations for the management of rheumatoid arthritis

    Cohort study

  34. Arthritis Rheumatol

    Late‐Onset Rheumatoid Arthritis and Air Pollution in a Multiethnic Cohort

    Cohort study

  35. RMD Open

    Sustained exposure to low- and high-income status and risk of all-cause mortality in individuals with rheumatoid arthritis: a population-based retrospective cohort study from 2010 to 2020

    Cohort study

  36. Lancet Rheumatol

    Certolizumab pegol, abatacept, tocilizumab or active conventional therapy in early rheumatoid arthritis: 48-week patient-reported outcomes from the NORD-STAR trial

    Secondary analysis

  37. Clin Exp Rheumatol

    Long-term low dose glucocorticoid therapy in rheumatoid arthritis: a systematic review with meta-analysis on cardiovascular effects

    Meta-analysis

  38. Lancet Rheumatol

    Time to pregnancy in women with rheumatoid arthritis who want to conceive treated according to a treat-to-target approach: a comparison of an observational cohort with a historical reference cohort

    Cohort study

  39. Arthritis Res Ther

    The association between methotrexate metabolism-related gene polymorphisms and therapeutic efficacy and toxicity in patients with rheumatoid arthritis

    Research article

  40. Semin Arthritis Rheum

    Target trial emulation of biologic and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis-associated interstitial lung disease

    Cohort study

All 1,564 Briefs in ExploreShowing Briefs 161–200 of 1,564, newest first